Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Otol Neurotol. 2023 Sep 1;44(8):804-808. doi: 10.1097/MAO.0000000000003973. Epub 2023 Aug 3.
The objective of this study is to evaluate the efficacy and outcomes of using a transmastoid approach with hydroxyapatite cement to repair lateral skull base cerebrospinal fluid (CSF) leaks.
Retrospective cohort study.
Tertiary-level care hospital.
Surgical patients 18 years or older between 2013 and 2022 with spontaneous CSF leak.
Trans-mastoid approach for skull base repair using hydroxyapatite cement.
Failure rate of repair; location and size of defect, patient demographic factors.
Of the 60 total defects (55 patients, 5 bilateral repairs) that underwent CSF leak repair using hydroxyapatite cement, the success rate was 91.66% (55 successful repairs). The average defect size in unsuccessful repairs was 1.15 cm compared with 0.71 cm for successful repairs. In addition, 80% (4/5) of the failed repairs were in the tegmen tympani region. Higher failure rate was noted in women (3/5) and in former smokers (4/5). Average time to recurrent symptoms was 1.75 years in the failed repair cohort. Of the patients with failed repairs, 4/5 were prescribed acetazolamide before their second procedure with successful second repair. In addition, five patients experienced postoperative headaches, three (5.4%) of whom required placement of VP shunts to relieve increased intracranial pressure. Two patients (3.6%) had complications of either infection or hearing loss.
Transmastoid approach utilizing hydroxyapatite is a successful approach for CSF leak repair, with a low complication and failure rate. Women, prior smoking history, and larger defects in the tegmen tympani region may need alternative materials or approach for repair. Long follow-up is warranted as recurrence of symptoms might be delayed. In cases of benign intracranial hypertension, adjuvant treatment with either acetazolamide or VP shunt placement may prevent failures.
本研究旨在评估使用羟基磷灰石水泥经乳突入路修复外侧颅底脑脊液(CSF)漏的疗效和结果。
回顾性队列研究。
三级护理医院。
2013 年至 2022 年间年龄在 18 岁及以上的自发性 CSF 漏患者。
使用羟基磷灰石水泥经乳突入路进行颅底修复。
修复失败率;缺陷的位置和大小、患者的人口统计学因素。
在 60 例(55 例患者,5 例双侧修复)接受羟基磷灰石水泥修复 CSF 漏的患者中,成功率为 91.66%(55 例修复成功)。修复失败的患者中缺陷平均大小为 1.15cm,而修复成功的患者中缺陷平均大小为 0.71cm。此外,80%(4/5)的修复失败发生在鼓室天盖区。女性(3/5)和曾吸烟者(4/5)的失败率更高。在修复失败的患者中,复发症状的平均时间为 1.75 年。在修复失败的患者中,4/5 在第二次手术前服用了乙酰唑胺,第二次手术均成功修复。此外,5 例患者术后出现头痛,其中 3 例(5.4%)需要放置脑室-心房分流管以缓解颅内压升高。2 例(3.6%)患者出现感染或听力损失并发症。
使用乳突入路结合羟基磷灰石是修复 CSF 漏的一种成功方法,其并发症和失败率均较低。女性、有吸烟史和鼓室天盖区较大的缺陷可能需要其他材料或方法进行修复。需要进行长期随访,因为症状可能会延迟复发。对于良性颅内压增高的患者,辅助使用乙酰唑胺或脑室-心房分流管可能有助于防止失败。